Page last updated: 2024-08-21

hydrazine and Neoplasms

hydrazine has been researched along with Neoplasms in 216 studies

Research

Studies (216)

TimeframeStudies, this research(%)All Research%
pre-199095 (43.98)18.7374
1990's27 (12.50)18.2507
2000's11 (5.09)29.6817
2010's55 (25.46)24.3611
2020's28 (12.96)2.80

Authors

AuthorsStudies
Ahnert, JR; Albittar, AA; Dalal, S; Dev, R; Fu, S; Hui, D; Karp, DD; Liu, S; Meric-Bernstam, F; Naing, A; Piha-Paul, SA; Rubin, L; Tsimberidou, AM; Yap, TA; Zarifa, A; Zhong, LL1
Carter, BW; Colen, R; Fu, S; Gong, J; Hong, DS; Janku, F; Karp, DD; McQuinn, L; Meric-Bernstam, F; Milton, DR; Naing, A; Piha-Paul, SA; Shah, J; Stephen, BA; Sulovic, S; Thein, KZ; Tsimberidou, A; Yap, TA1
Addison, CL; Brun, EMSP; Calvert, ND; Garipov, R; Kirby, A; Melkus, G; Shuhendler, AJ; Suchý, M1
Araújo, TG; da Costa Guerra, JF; de Oliveira Júnior, RJ; de Souza Bontempo, NJ; de Souza, TR; Goulart, LR; Guerra, W; Lima, PMAP; Lino, RC; Machado, PHA; Martins, IC; Morelli, S; Orsolin, PC; Paixão, DA; Sousa, LM; Teixeira, SC; Van Petten de Vasconcelos Azevedo, F1
Hanaoka, M; Nishie, K; Sato, S1
Das, S; Das, U; Dimmock, JR; Hall, SC; Hossain, M; Roayapalley, PK; Roth, SM; Wiggington, PJ1
Chen, CH; Fang, ZY; Lv, PC; Ni, LQ; Sun, J; Wu, YF; Zhang, YH; Zheng, Q1
Bhatta, R; Han, J; Li, H; Wang, H; Zhou, J1
Ding, K; Duan, L; Fu, R; Guo, Y; Liu, Z; Shen, H1
Adhikari, N; Banerjee, S; Biswas, S; Ghosh, B; Jha, T; Patel, T; Paul, M; Pulya, S; Routholla, G1
Fukasawa, K; Hanada, K; Hayashi, Y; Hinata, H; Hirai, H; Imai, S; Itoh, F; Ohfusa, R; Takayama, K1
Ding, Y; Liu, B; Lu, L; Zheng, P; Zhou, C1
Adhikari, N; Baidya, SK; Banerjee, S; Ghosh, B; Jha, T1
Guo, M; Hou, G; Li, Z; Qian, J; Suo, A; Wang, J; Wang, Y; Xu, W1
Gao, J; He, W; Huang, S; Song, M; Wu, X; Zhao, Z1
Chen, W; Li, L; Liu, Y; Zeng, X1
Penketh, P; Shyam, K; Williamson, H1
Faisal, A; Furqan, M; Mithani, A; Saleem, RSZ; Ullah, R; Zahra, R1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Baumann, RP; Penketh, PG; Shyam, K; Williamson, HS1
Fonseca, GWPD; von Haehling, S1
Hariyanto, TI; Kurniawan, A1
Bean, S; Carter, BW; Colen, R; Gong, J; Janku, F; Karp, DD; McQuinn, L; Meric-Bernstam, F; Milton, DR; Naing, A; Ogbonna, DC; Pant, S; Piha-Paul, SA; Shah, J; Subbiah, V; Thein, KZ; Tsimberidou, A; Zarifa, A1
Gong, W; Kleist, C; Müller-Tidow, C; Neuber, B; Ni, M; Sauer, T; Schmitt, A; Schmitt, M; Schubert, ML; Sellner, L; Stock, S; Wang, L; Wang, S; Yao, H1
Guo, Y; He, N; Li, R; Lu, L; Wang, J; Wu, L; Zhang, L; Zhang, X; Zhen, H; Zhou, M1
Basen-Engquist, K; Bruera, E; Dev, R; Fellman, BM; Hui, D; Maddi, R; Reuben, JM; Shete, S; Williams, JL; Yennurajalingam, S1
Kisby, GE; Spencer, PS1
Asai, A; Fukunishi, S; Goto, M; Higuchi, K; Nishiguchi, S; Nishikawa, H1
Chen, P; Dong, Y; Liang, G; Wang, F; Zheng, Z; Zhu, Y1
Kurokawa, T; Ohkohchi, N1
Currow, DC; Skipworth, RJ1
Garcia, JM; Graf, SA1
Bauer, S; Burgess, P; Doerfel, S; Forget, F; Kalambakas, S; Karaszewska, B; Khan, D; Mostafa Kamel, Y; Safran, H; Winer, ES1
Garcia, JM1
Chuai, Y; Dai, G; Nie, W; Wang, A; Zhang, X1
Crawford, J2
Chen, C; Sun, W; Wang, P; Wang, X; Wang, Y1
Childs, DS; Jatoi, A1
Burke, RT; Doak, AE; Marcus, JM; Orth, JD; Park, S1
Choi, YJ; Hai, PT; Han, SB; Huan, LC; Huong, LT; Kang, JS; Linh, NTP; Nam, NH; Park, EJ; Phuong, CV; Thuan, NT; Tran, PT; Truc, LC1
Jin, Y; Qiang, W; Shen, A; Zhang, F1
Gaidhane, A; Gaidhane, S; Khatib, MN; Quazi, ZS1
Chen, Z; Huang, W; Liu, S; Meng, X; Shi, Y; Song, L; Zhao, M; Zhao, Q; Zou, L1
Advani, PG; Advani, SM; Jafri, SH; VonVille, HM1
Kasvis, P; Vigano, A; Vigano, M1
Malik, JS; Yennurajalingam, S1
Cen, X; Jie, H; Li, Y; Li, Z; Lin, Y; Liu, C; Qian, X; Tao, L; Yang, S; Zhang, H; Zhao, Y; Zhou, Y; Zuo, Z1
Dong, Y; Gong, P; Hu, H; Li, M; Wang, R; Zhang, X; Zhao, Y1
Gibiansky, E; Hayes, S; Johnson, BM; Mudd, PN; Ouellet, D; Williams, D1
Kumar, P; Narasimhan, B1
Barnard, S; Bear, MD; Bernabe, LF; Borgatti, A; Henson, M; Ito, D; Jensen, K; Kauffman, M; Kisseberth, WC; London, CA; McCauley, D; Modiano, JF; Pennell, ML; Saint-Martin, JR; Shacham, S; Wilson, H1
Baumann, RP; Ishiguro, K; Penketh, PG; Sartorelli, AC; Shyam, K; Zhu, R1
Chatrou, M; Kusters, D; Reutelingsperger, CP; Schurgers, L; Ungethüm, L1
Brissos, RF; Caballero, AB; Carvalho Pires, W; Caubet, A; dos Santos Mello, FM; Gamez, P; Massera, C; Roubeau, O; Silveira-Lacerda, Ede P; Teat, SJ; Torrents, E1
Forget, F; Hartner, L; Johnson, BM; Karaszewska, B; Kumar, K; Mayer, B; Messam, CA; Mostafa Kamel, Y; Ramlau, R; Richards, DA; Safran, H; Winer, ES1
Allen, S; Boccia, RV; Duus, EM; Friend, J; Garcia, JM; Graham, CD; Yan, Y1
Baracos, VE1
King, I; Nassar, AF; Wisnewski, A1
Kuter, DJ1
Cerezuela Fuentes, P; García Coronel, M; García Lagunar, MH; Gutiérrez-Meca Maestre, DP; Martínez Ortiz, MJ; Martínez Penella, M1
Criscitiello, C; Curigliano, G; Di Leo, M; Esposito, A; Gelao, L; Liuzzi, R; Locatelli, M; Massaro, M; Milani, A; Minchella, I; Pravettoni, G1
Meriggi, F1
Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R1
Aiello, F; Garofalo, A; Grande, F; Neamati, N1
Mahipal, A; Malafa, M1
Chen, P; Li, G; Liang, G; Tang, W; Wang, L; Yuan, Y; Zhang, H; Zheng, Z; Zhu, H1
Hosseinimehr, SJ; Torabizadeh, SA1
Azmi, AS; Mohammad, RM1
Bai, Y; Hu, Y; Hua, Z; Xu, J; Yu, X; Zhao, Y; Zhao, Z1
Burd, CE; Crochiere, M; Elloul, S; Elnaggar, O; Farren, MR; Hennessey, RC; Kashyap, T; Kendra, K; Klebanov, B; Landesman, Y; Lesinski, GB; Shakya, R; Young, G1
Wang, M; Yu, N1
Baumann, RP; Penketh, PG; Sartorelli, AC; Seow, HA; Shyam, K1
Pigneux, A1
Aiello, F; Cao, X; Garofalo, A; Grande, F; Neamati, N; Oshima, T; Plasencia, C; Sanchez, T; Yamada, R1
Barak, Y; Contag, CH; Debeer, D; Matin, A; Schreiber, F; Thorne, SH1
Bondarenko, IN; Jagiello-Gruszfeld, A; Kellum, A; Messam, C; Mostafa Kamel, Y; Patwardhan, R1
Bussel, JB; Pinheiro, MP1
Du, J; King, I; Nassar, AE1
Bailly, C; Guilbaud, N; Guminski, Y; Imbert, T; Kruczynski, A; Le Pape, A; Lerondel, S; Pesnel, S; Pillon, A1
Huo, L; Wang, G; Xu, W; Zhang, D; Zhao, G1
Akintujoye, OM; Baumann, RP; Glazer, PM; Ishiguro, K; Liu, Y; Penketh, PG; Rockwell, S; Sartorelli, AC; Seow, HA; Shyam, K1
Akama, TO; Bobkov, AA; Fukuda, M; Fukuda, MN; Hatakeyama, S; Nakayama, J; Ohyama, C; Shibata, TK; Sugihara, K; Takano, Y; Tamura, N; Wong, SM1
Ghosh, S; Kumar, D; Maruthi Kumar, N; Shah, K1
Barsoum, J; Beaudette-Zlatanova, BC; Blackman, RK; Chimmanamada, D; Chu, J; Inoue, T; Koya, K; Lu, R; Nagai, M; Shin Ogawa, L; Vo, NH; Wada, Y1
Hebar, A; Rütgen, BC; Selzer, E1
Luo, Z; Nitin, N; Samadzadeh, KM; Tikekar, RV1
ROSS, WC; WARWICK, GP1
ANDERSON, W; EVANS, HD; MAYNEORD, WV; ROSEN, D1
BOLLAG, W; GRUNBERG, E1
BERNEIS, K; BOLLAG, W; KAISER, A; KOFLER, M; LANGEMANN, A1
AMIEL, JL; BERUMEN, L; BRULE, G; CATTAN, A; MATHE, G; SCHNEIDER, M; SCHWARZENBERG, L; SCHWEISGUTH, O1
KRUGLOVA, GV1
CHISTOVICH, AN; LISITSIN, MS; POPOV, VI; PROKHODTSEV, II; RESHETOV, AI; RYZHKOV, SV; SITENKO, VM; ZERNOV, AI1
CHEKULAEV, G; TARASENKO, A1
VILNER, LS1
RABKOVA, LM1
IAROSHEVSKII, FIu; VOLOKHONSKAIA, ML; VORONKO, ND; VYSHESLAVTSEV, SI1
BACKHOUSE, TW; SICHER, K1
CHANG, CN; HU, Y; WANG, TT1
ISHIGURO, M; KAMETANI, T; MIZUNO, D; OGASAWARA, K; SATOH, Y; SHIBUYA, S; UMEZAWA, O1
ISHIGURO, M; KAMETANI, T; MIZUNO, D; UMEZAWA, O; YAGI, H1
ISHIGURO, M; KAMETANI, T; MIZUNO, D; OGASAWARA, K; SHIBUYA, S; UMEZAWA, O1
BOLLAG, W; D ALESSANDRI, A; KEEL, HJ; MARTZ, G1
LANCASTER, MC; ROE, FJ1
GROGAN, CH; RICE, LM1
ADAMSON, RH; DAVIDSON, JD; DION, RL; LOO, TL1
CHENG, CC; FRENCH, FA; NYBERG, WH; PODREBARAC, EG1
GARCES, B; SANZ ANTON, J1
BIANCIFIORI, C; BUCCIARELLI, E; CLAYSON, DB; SANTILLI, FE1
KARNOFSKY, DA1
AMIEL, JL; CATTAN, A; MATHE, G; SCHLUMBERGER, JR; SCHNEIDER, M; SCHWARZENBERG, L1
FINGER, H; FRETZDORFF, AM; SCHNEIDER, F; SEYNSCHE, K; WEITZEL, G1
BAENAHERRERA, L; GONZALEZRODRIGUEZ, D; GOSALVEZGOSALVEZ, M; GUIJOSAPERNUS, J1
TODD, ID1
NEWTON, KA; WESTBURY, G; WHITE, WF1
ABATUCCI, JS; JACOB, P; VIALLANEIX, JP1
GIUSEPPE, M; PAOLO, I1
BRUNNER, KW; YOUNG, CW1
BRULE, G; GRISCELLI, C; SCHLUMBERGER, JR1
MARTIN, H; SCHUBERT, C; WOERNER, W1
KEIDAN, SE2
Chu, E; Clairmont, C; Egorin, M; Kummar, S; Modiano, M; Murren, J; Sznol, M1
Penketh, PG; Rockwell, S; Sartorelli, AC; Seow, HA; Shyam, K1
Ishiguro, K; Penketh, PG; Sartorelli, AC; Shyam, K1
Kennedy, N; Krishnadasan, A; Morgenstern, H; Ritz, B; Zhao, Y1
Blot, WJ; Boice, JD; Brill, AB; Cohen, SS; Fryzek, JP; Henderson, BE; Marano, DE; McLaughlin, JK; Mumma, MT1
Berkenblit, A; Dahl, TA; Dezube, BJ; Eder, JP; Ryan, DP; Seiden, MV; Sherman, ML; Supko, JG; Tatsuta, N1
Tatarinov, YS1
Suskind, RR1
Bonsall, J; Boreham, J; Doll, R; Wald, N1
Block, JB; Chlebowski, RT; Heber, D; Richardson, B1
Cameron, IL1
Regelson, W1
Gold, J6
Danova, LA; Filov, VA; Gershanovich, ML; Ivin, BA2
Takemura, N1
Toth, B1
Densem, JW; Doll, R; Morris, J; Wald, NJ1
Filov, VA1
Bruera, E3
Herbert, V1
DeGraff, W; Gamson, J; Keefer, LK; Krishna, MC; Mitchell, JB; Wink, DA1
Ovesen, LF1
Jenks, S1
Bruera, E; Vigano, A; Watanabe, S1
Wheeler, BM1
Veggeberg, S1
Kaegi, E1
Tannock, IF; Warr, DG1
Bozzetti, F1
Bégin, M; Kaegi, E1
Froines, J; Moncau, J; Morgenstern, H; Ritz, B1
Levey, GS; Vesely, DL1
Back, KC; Carter, VL; Thomas, AA1
Regelson, W; Spremulli, E; Wampler, GL1
Baló, J1
Conso, F; Efthymiou, ML; Garnier, R; Gaultier, M; Riboulet, G1
Danova, LA; Filov, VA; Gershanovich, ML; Kondrat'ev, VB; Seĭts, IF1
Friedman, MA; Hawkins, MJ1
Gorter, R1
Breĭvis, PV; Danova, LA; Dement'eva, NP; Filov, VA; Gershanovich, ML; Ivin, BA; Kas'ianenko, IV; Lisitsa, AM; Mindlin, SS; Ragaĭshene, VP1
Burch, PA; Ellison, NM; Goldberg, RM; Loprinzi, CL; Michalak, JC1
Smigel, K1
Denisov, VL; Savchenkov, MF1
Alho, J; Kauppinen, T; Sundquist, E1
Chlebowski, RT; Heber, D1
Block, JB; Bulcavage, L; Chi, J; Chlebowski, JS; Chlebowski, RT; Grosvenor, M; Heber, D; Oktay, E; Scrooc, M; Tsunokai, R1
Wald, NJ1
Falkson, G; Falkson, HC2
Rastetter, J; Stockhusen, G; Theml, H; Trepel, F1
Alexanian, R; Frei, E; Howe, CD; Leary, WV; Samuels, ML1
Lesobre, R; Ruffino, J; Tubiana, M1
Enomoto, M; Saito, M1
Clavel, B1
Hawks, A; Hicks, RM; Holsman, JW; Magee, PN1
Krueger, GR1
Wie, H1
Hunter, B; Mawdesley-Thomas, LE; Worden, AN1
Shimizu, H; Toth, B1
Brunner, KW1
Seidenglanz, G1
Massenti, S; Polese, E; Rossi-Torelli, M1
Hanley, T; Udall, V; Weatherall, M1
Chahinian, P; Depierre, A; Israel, L1
el-Akkad, SM; Garrett, MJ; Glazebrook, GA; Shakir, MA1
Magee, PN1
Connors, TA1
Bosnar, M; Krieg, R; Ringleb, D; Sauer, D; Steckenmesser, R1
Cunningham, T; Horton, J; Hosley, H; Olson, KB; Paladine, WJ; Pratt, KL; Sullivan, J; Treble, DH1
Billmeier, GJ; Holton, CP1
Furue, H; Hattori, T; Kubo, A; Nakao, I; Yamana, T1
Hammer, B1
Massenti, S; Perri, G1
Agati, G1
DeVita, VT; Rall, DP1
Bucher, U; Kummer, H1
Amiel, JL; Bernard, J; Bessis, M; Dreyfus, B; Najean, Y; Péquignot, H; Seligmann, M1
De Smedt, J; Kenis, Y; Tagnon, HJ1
Kühböck, J; Mannheimer, E1

Reviews

51 review(s) available for hydrazine and Neoplasms

ArticleYear
Anamorelin for cancer cachexia.
    Drugs of today (Barcelona, Spain : 1998), 2022, Volume: 58, Issue:3

    Topics: Anorexia; Cachexia; Humans; Hydrazines; Neoplasms; Oligopeptides

2022
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
    Journal of experimental & clinical cancer research : CR, 2022, Sep-12, Volume: 41, Issue:1

    Topics: Copper; Humans; Hydrazines; Ionophores; Neoplasms; Platinum; Proteasome Inhibitors

2022
Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
    Redox biology, 2023, Volume: 67

    Topics: Copper; Humans; Hydrazines; Neoplasms; Reactive Oxygen Species

2023
Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis.
    BMC pharmacology & toxicology, 2023, Dec-01, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Benzoates; Hemorrhage; Humans; Hydrazines; Neoplasms; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:7

    Topics: Anorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; Humans; Hydrazines; Lung Neoplasms; Neoplasms; Oligopeptides

2021
Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment.
    Cancer treatment and research communications, 2021, Volume: 27

    Topics: Anorexia; Appetite; Clinical Trials, Phase III as Topic; Eicosapentaenoic Acid; Growth Differentiation Factor 15; Humans; Hydrazines; Mirtazapine; Neoplasms; Oligopeptides; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Thalidomide; Toll-Like Receptor 4; Treatment Outcome

2021
Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease.
    Chemical research in toxicology, 2021, 09-20, Volume: 34, Issue:9

    Topics: Animals; Carcinogens; DNA Damage; DNA Repair; Gene Expression Regulation; Humans; Hydrazines; Liver; Neoplasms; Neurodegenerative Diseases; Neurons; Neurotoxins

2021
Cancer Cachexia: Its Mechanism and Clinical Significance.
    International journal of molecular sciences, 2021, Aug-06, Volume: 22, Issue:16

    Topics: Anilides; Animals; Cachexia; Dietary Supplements; Disease Management; Humans; Hydrazines; Neoplasms; Oligopeptides

2021
Platelets in liver disease, cancer and regeneration.
    World journal of gastroenterology, 2017, May-14, Volume: 23, Issue:18

    Topics: Animals; Benzoates; Blood Platelets; Cell Movement; Clinical Trials as Topic; End Stage Liver Disease; Fibrosis; Hepatic Stellate Cells; Humans; Hydrazines; Killer Cells, Natural; Liver; Liver Diseases; Liver Regeneration; Neoplasm Metastasis; Neoplasms; Pyrazoles; Regeneration; Shear Strength; Thrombocytopenia; Thrombopoietin

2017
The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Future oncology (London, England), 2017, Volume: 13, Issue:20

    Topics: Anorexia; Body Composition; Body Weight; Cachexia; Clinical Trials as Topic; Disease Management; Humans; Hydrazines; Neoplasms; Oligopeptides; Treatment Outcome

2017
Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Animals; Anorexia; Cachexia; Humans; Hydrazines; Neoplasms; Oligopeptides; Quality of Life; Receptors, Ghrelin

2017
What is next after anamorelin?
    Current opinion in supportive and palliative care, 2017, Volume: 11, Issue:4

    Topics: Anorexia; Biomarkers; Cachexia; Drug Approval; Humans; Hydrazines; Neoplasms; Oligopeptides; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Ghrelin; Research Design

2017
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.
    The Cochrane database of systematic reviews, 2017, 11-27, Volume: 11

    Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Humans; Hydrazines; Middle Aged; Neoplasms; Pyrazoles; Randomized Controlled Trials as Topic; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin

2017
A hunger for hunger: a review of palliative therapies for cancer-associated anorexia.
    Annals of palliative medicine, 2019, Volume: 8, Issue:1

    Topics: Adrenal Cortex Hormones; Anorexia; Appetite Stimulants; Cachexia; Cannabinoids; Humans; Hydrazines; Neoplasms; Oligopeptides; Palliative Care

2019
The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews.
    BMC complementary and alternative medicine, 2018, Aug-09, Volume: 18, Issue:1

    Topics: Acupuncture Therapy; Adult; Anorexia; Cachexia; Dietary Supplements; Evidence-Based Medicine; Humans; Hydrazines; Medicine, Chinese Traditional; Neoplasms; Oligopeptides; Plant Extracts

2018
Ghrelin as a Promising Therapeutic Option for Cancer Cachexia.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 48, Issue:5

    Topics: Animals; Appetite; Cachexia; Cell Proliferation; Ghrelin; Humans; Hydrazines; Mitochondria; Neoplasms; Oligopeptides; Receptors, Ghrelin

2018
Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.
    BMC cancer, 2018, Nov-27, Volume: 18, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cachexia; Clinical Trials as Topic; Cytokines; Disease Management; Female; Humans; Hydrazines; Neoplasm Staging; Neoplasms; Oligopeptides; Quality of Life; Treatment Outcome

2018
Health-related quality of life across cancer cachexia stages.
    Annals of palliative medicine, 2019, Volume: 8, Issue:1

    Topics: Adrenal Cortex Hormones; Anorexia; Appetite Stimulants; Cachexia; Cannabinoids; Cyproheptadine; Female; Health Status; Humans; Hydrazines; Male; Megestrol Acetate; Middle Aged; Neoplasms; Oligopeptides; Quality of Life; Serotonin Antagonists; Severity of Illness Index; Stress, Psychological; Surveys and Questionnaires

2019
Prokinetics and ghrelin for the management of cancer cachexia syndrome.
    Annals of palliative medicine, 2019, Volume: 8, Issue:1

    Topics: Cachexia; Forecasting; Gastrointestinal Agents; Ghrelin; Humans; Hydrazines; Metoclopramide; Neoplasms; Oligopeptides

2019
Hydrazides/hydrazones as antimicrobial and anticancer agents in the new millennium.
    Mini reviews in medicinal chemistry, 2013, Volume: 13, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Proliferation; Fungi; Humans; Hydrazines; Hydrazones; Neoplasms

2013
Managing thrombocytopenia associated with cancer chemotherapy.
    Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:4

    Topics: Antineoplastic Agents; Benzoates; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gemcitabine; Humans; Hydrazines; Neoplasms; Platelet Count; Platelet Transfusion; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoiesis; Thrombopoietin; Treatment Outcome

2015
Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Cancer treatment reviews, 2015, Volume: 41, Issue:9

    Topics: Animals; Anorexia; Cachexia; Humans; Hydrazines; Neoplasms; Oligopeptides; Receptors, Ghrelin; Syndrome

2015
Cancer Cachexia: One Step Ahead.
    Reviews on recent clinical trials, 2015, Volume: 10, Issue:3

    Topics: Cachexia; Combined Modality Therapy; Disease Progression; Female; Humans; Hydrazines; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Nutritional Support; Oligopeptides; Physical Therapy Modalities; Prognosis; Severity of Illness Index; Treatment Outcome

2015
Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity.
    Mini reviews in medicinal chemistry, 2016, Volume: 16, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Drug Discovery; Humans; Hydrazines; Molecular Structure; Neoplasms; Quinoxalines

2016
Clinical results in cachexia therapeutics.
    Current opinion in clinical nutrition and metabolic care, 2016, Volume: 19, Issue:3

    Topics: Amides; Anilides; Antineoplastic Agents; Cachexia; Combined Modality Therapy; Diet, Healthy; Drugs, Investigational; Exercise; Humans; Hydrazines; Ligands; Muscle, Skeletal; Neoplasms; Oligopeptides; Receptors, Androgen; Receptors, Ghrelin; Wasting Syndrome

2016
Importins and exportins as therapeutic targets in cancer.
    Pharmacology & therapeutics, 2016, Volume: 164

    Topics: Active Transport, Cell Nucleus; Animals; Cell Nucleus; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Neoplasms; ran GTP-Binding Protein; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Triazoles

2016
The Influence of Co-Ligands on Improving Tumor Targeting of
    Mini reviews in medicinal chemistry, 2017, Volume: 17, Issue:2

    Topics: Animals; Chelating Agents; Humans; Hydrazines; Ligands; Neoplasms; Nicotinic Acids; Organotechnetium Compounds; Peptides; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2017
Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:5

    Topics: Anorexia; Cachexia; Female; Humans; Hydrazines; Neoplasms; Oligopeptides; Quality of Life; Syndrome

2017
Anticancer drug discovery targeting DNA hypermethylation.
    Current medicinal chemistry, 2008, Volume: 15, Issue:14

    Topics: 4-Aminobenzoic Acid; Adenosine; Animals; Antineoplastic Agents; Cytidine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Design; Enzyme Inhibitors; Humans; Hydrazines; Neoplasms; Oligonucleotides, Antisense; para-Aminobenzoates

2008
Laromustine, a sulfonyl hydrolyzing alkylating prodrug for cancer therapy.
    IDrugs : the investigational drugs journal, 2009, Volume: 12, Issue:1

    Topics: Aged; Animals; Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Humans; Hydrazines; Isocyanates; Middle Aged; Neoplasms; Prodrugs; Sulfonamides

2009
Eltrombopag.
    Cancer treatment and research, 2011, Volume: 157

    Topics: Animals; Benzoates; Clinical Trials as Topic; Humans; Hydrazines; Mice; Neoplasms; Pyrazoles; Thrombocytopenia

2011
NATURAL, METALLIC AND OTHER SUBSTANCES, AS CARCINOGENS.
    British medical bulletin, 1964, Volume: 20

    Topics: Aluminum; Arsenic; Aspergillus; Beryllium; Carcinogens; Carrageenan; Citrus; Croton Oil; Food Contamination; Fruit; Griseofulvin; Herbicides; Humans; Hydrazines; Insecticides; Iron; Metals; Neoplasms; Neoplasms, Experimental; Penicillium; Plants, Edible; Polysaccharides; Rats; Research; Senecio; Tannins; Thiourea

1964
[Segidrin: a new-type antineoplastic agent].
    Voprosy onkologii, 1994, Volume: 40, Issue:1-3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Gluconeogenesis; Humans; Hydrazines; Mice; Neoplasms; Neoplasms, Experimental; Rats; Time Factors

1994
Is the pharmacological treatment of cancer cachexia possible?
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1993, Volume: 1, Issue:6

    Topics: Adrenal Cortex Hormones; Anorexia; Antineoplastic Agents; Cachexia; Cannabinoids; Clinical Protocols; Cyproheptadine; Enteral Nutrition; Humans; Hydrazines; Neoplasms; Nutritional Status; Parenteral Nutrition; Progestins; Quality of Life

1993
Anorexia and cachexia in advanced cancer patients.
    Cancer surveys, 1994, Volume: 21

    Topics: Adrenal Cortex Hormones; Animals; Anorexia; Antineoplastic Agents; Cachexia; Cannabinoids; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyproheptadine; Enteral Nutrition; Gastrointestinal Agents; Humans; Hydrazines; Mice; Neoplasms; Nutritional Physiological Phenomena; Parenteral Nutrition; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Research; Terminal Care

1994
Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998, May-19, Volume: 158, Issue:10

    Topics: Antineoplastic Agents; Cachexia; Drugs, Investigational; Gluconeogenesis; Humans; Hydrazines; Neoplasms; Phosphoenolpyruvate Carboxykinase (GTP)

1998
Hydrazine.
    IARC monographs on the evaluation of carcinogenic risks to humans, 1999, Volume: 71 Pt 3

    Topics: Animals; Carcinogenicity Tests; Carcinogens; Humans; Hydrazines; Mutagenicity Tests; Mutagens; Neoplasms; Neoplasms, Experimental

1999
Occupational hazards of missile operations with special regard to the hydrazine propellants.
    Aviation, space, and environmental medicine, 1978, Volume: 49, Issue:4

    Topics: Alopecia; Animals; Behavior, Animal; Body Weight; Carcinogens; Dimethylhydrazines; Dose-Response Relationship, Drug; Environmental Exposure; Female; Hemolysis; Humans; Hydrazines; Liver; Male; Maximum Allowable Concentration; Metabolism; Monomethylhydrazine; Mutation; Neoplasms; Occupational Diseases; Respiratory Tract Diseases; Seizures; Water Pollution, Chemical

1978
Clinical management of anorexia and cachexia in patients with advanced cancer.
    Oncology, 1992, Volume: 49 Suppl 2

    Topics: Anorexia; Cachexia; Cannabinoids; Cyproheptadine; Humans; Hydrazines; Megestrol; Megestrol Acetate; Methylprednisolone; Neoplasms

1992
Current pharmacological management of anorexia in cancer patients.
    Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:1

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Cachexia; Cannabinoids; Cyproheptadine; Humans; Hydrazines; Neoplasms

1992
Management of anorexia-cachexia associated with cancer and HIV infection.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:9 Suppl

    Topics: Anorexia; Antineoplastic Agents; Cachexia; Dronabinol; HIV Infections; Humans; Hydrazines; Megestrol; Megestrol Acetate; Metoclopramide; Neoplasms; Palliative Care

1991
Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9

    Topics: Anorexia; Cachexia; Cyproheptadine; Dexamethasone; Double-Blind Method; Humans; Hydrazines; Neoplasms; Weight Gain

1990
[Hydrazine derivatives--potentially hazardous carcinogenic chemical compounds].
    Voprosy onkologii, 1988, Volume: 34, Issue:9

    Topics: Animals; Carcinogens; Dose-Response Relationship, Drug; Humans; Hydrazines; Neoplasms; Neoplasms, Experimental; Occupational Diseases; Structure-Activity Relationship

1988
Hydrazine sulfate: a current perspective.
    Nutrition and cancer, 1987, Volume: 9, Issue:2-3

    Topics: Cachexia; Clinical Trials as Topic; Double-Blind Method; Gluconeogenesis; Humans; Hydrazines; Neoplasms; Parenteral Nutrition, Total

1987
Metabolic abnormalities in cancer patients: carbohydrate metabolism.
    The Surgical clinics of North America, 1986, Volume: 66, Issue:5

    Topics: Animals; Blood Glucose; Cachexia; Humans; Hydrazines; Neoplasms

1986
[Naturally occurring chemical carcinogens].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1970, Volume: 15, Issue:5

    Topics: Aflatoxins; Alkaloids; Animals; Anthraquinones; Anti-Bacterial Agents; Carcinogens; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Glycosides; Humans; Hydrazines; Lactones; Liver Neoplasms; Mycotoxins; Neoplasms; Oils; Peptides; Plants, Edible; Pyrrolidines; Tannins

1970
Morphology of chemical immunosuppression.
    Advances in pharmacology and chemotherapy, 1972, Volume: 10

    Topics: Alkylating Agents; Anti-Bacterial Agents; Antibody Formation; Antigen-Antibody Reactions; Antineoplastic Agents; Autoimmune Diseases; Binding Sites, Antibody; Enzymes; Hormones; Humans; Hydrazines; Immune System Diseases; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Mitosis; Molecular Biology; Mycophenolic Acid; Neoplasms; Nitrosourea Compounds; Poly I-C; Pyrans; Transplantation, Homologous

1972
[Progress in the drug therapy of cancer].
    Medizinische Klinik, 1968, Apr-26, Volume: 63, Issue:17

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Cytarabine; Daunorubicin; Drug Synergism; Humans; Hydrazines; Hydroxyurea; Neoplasms; Nitroso Compounds; Picolinic Acids; Pyrogallol; Quinolines; Streptonigrin; Urea

1968
[Chemotherapy of malignant tumors. 44].
    Pharmazeutische Praxis, 1970, Volume: 6

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Androgens; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Azirines; Carbamates; Colchicine; Dichlorodiphenyldichloroethane; Esters; Estrogens; Ethers, Cyclic; Ethylamines; Excitatory Amino Acid Antagonists; Folic Acid Antagonists; Heterocyclic Compounds; Hormones; Hydrazines; Mannitol; Neoplasms; Phytotherapy; Pipobroman; Plants, Medicinal; Plants, Toxic; Podophyllum; Purines; Pyrimidines; Sulfonic Acids; Triazines; Vinblastine; Vincristine

1970
An industrial view of current practice in predicting drug toxicity.
    British medical bulletin, 1970, Volume: 26, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Cataract; Clinical Trials as Topic; Drug Industry; Fertility; Humans; Hydrazines; Neoplasms; Poisoning; Poliovirus Vaccine, Oral; Thiocarbamates; Toxicology; United States; United States Food and Drug Administration

1970

Trials

29 trial(s) available for hydrazine and Neoplasms

ArticleYear
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
    Investigational new drugs, 2022, Volume: 40, Issue:1

    Topics: Adult; Aged; Anorexia; Antiemetics; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Neoplasms; Olanzapine; Triazoles; Vomiting; Young Adult

2022
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
    Investigational new drugs, 2022, Volume: 40, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hydrazines; Lung Neoplasms; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Triazoles; Vomiting

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
    Investigational new drugs, 2021, Volume: 39, Issue:5

    Topics: Active Transport, Cell Nucleus; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Receptors, Cytoplasmic and Nuclear; Topotecan; Triazoles

2021
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.
    International journal of hematology, 2017, Volume: 106, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Benzoates; Deoxycytidine; Female; Gemcitabine; Humans; Hydrazines; Male; Middle Aged; Neoplasms; Pyrazoles; Thrombocytosis

2017
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Acrylamides; Active Transport, Cell Nucleus; Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Nucleus; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Hydrazines; Inhibitory Concentration 50; Male; Neoplasms; Quality of Life

2014
Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study.
    Cancer medicine, 2015, Volume: 4, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Hydrazines; Male; Middle Aged; Neoplasm Staging; Neoplasms; Platelet Count; Pyrazoles; Treatment Outcome

2015
    ChemCatChem, 2015, Apr-07, Volume: 7, Issue:7

    Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult

2015
A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.
    Current medical research and opinion, 2010, Volume: 26, Issue:10

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydrazines; Male; Middle Aged; Neoplasms; Paclitaxel; Placebos; Platelet Count; Polypharmacy; Pyrazoles; Treatment Outcome; Young Adult

2010
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
    Investigational new drugs, 2005, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Hydrazines; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Sulfonamides; Thrombocytopenia

2005
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jan-15, Volume: 13, Issue:2 Pt 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Hydrazines; Male; Maximum Tolerated Dose; Middle Aged; Models, Chemical; Neoplasms; Paclitaxel; Time Factors; Treatment Outcome

2007
Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Cancer research, 1984, Volume: 44, Issue:2

    Topics: Adult; Aged; Body Weight; Cachexia; Carbohydrate Metabolism; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hydrazines; Male; Middle Aged; Neoplasms

1984
The 'grand conspiracy' against the cancer cure.
    JAMA, 1980, Jan-25, Volume: 243, Issue:4

    Topics: Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Humans; Hydrazines; Intestinal Neoplasms; Neoplasms; Skin Neoplasms

1980
Isoniazid--an attempt at retrospective prediction. A report of an ad hoc expert groups of the International Commission for Protection Against Environmental Mutagens and Carcinogens.
    Mutation research, 1980, Volume: 76, Issue:1

    Topics: Acetyltransferases; Biotransformation; Carcinogens; Chromosomes; Clinical Trials as Topic; Drug Evaluation, Preclinical; Hydrazines; Inactivation, Metabolic; Isoniazid; Liver; Lung Neoplasms; Mutagens; Neoplasms; Risk; Teratogens; Tuberculosis, Pulmonary

1980
Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.
    Nutrition and cancer, 1981, Volume: 3, Issue:1

    Topics: Appetite; Body Weight; Clinical Trials as Topic; Female; Humans; Hydrazines; Neoplasms; Nutritional Physiological Phenomena

1981
Results of clinical study antitumor action of hydrazine sulfate.
    Nutrition and cancer, 1981, Volume: 3, Issue:1

    Topics: Abdominal Neoplasms; Aged; Clinical Trials as Topic; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neuroblastoma; Sarcoma

1981
Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients.
    Investigational new drugs, 1995, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Fibromatosis, Aggressive; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Male; Middle Aged; Neoplasms; Neuroblastoma

1995
Clinical study of hydrazine sulfate in advanced cancer patients.
    Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Neoplasms

1979
[Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Voprosy onkologii, 1975, Volume: 21, Issue:1

    Topics: Adult; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Hodgkin Disease; Humans; Hydrazines; Lethal Dose 50; Leukemia, Experimental; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Rats; Sarcoma 37; Skin Neoplasms; Sulfates; Time Factors

1975
Clinical management of anorexia and cachexia in patients with advanced cancer.
    Oncology, 1992, Volume: 49 Suppl 2

    Topics: Anorexia; Cachexia; Cannabinoids; Cyproheptadine; Humans; Hydrazines; Megestrol; Megestrol Acetate; Methylprednisolone; Neoplasms

1992
[The results of a clinical study of the preparation hydrazine sulfate].
    Voprosy onkologii, 1990, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Hydrazines; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasms; Remission Induction; Tablets, Enteric-Coated; Time Factors

1990
Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9

    Topics: Anorexia; Cachexia; Cyproheptadine; Dexamethasone; Double-Blind Method; Humans; Hydrazines; Neoplasms; Weight Gain

1990
Hydrazine sulfate used in cancer patients.
    Journal of the National Cancer Institute, 1990, Feb-21, Volume: 82, Issue:4

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Glucose; Humans; Hydrazines; Neoplasms

1990
Hydrazine sulfate: a current perspective.
    Nutrition and cancer, 1987, Volume: 9, Issue:2-3

    Topics: Cachexia; Clinical Trials as Topic; Double-Blind Method; Gluconeogenesis; Humans; Hydrazines; Neoplasms; Parenteral Nutrition, Total

1987
Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience.
    Cancer, 1987, Feb-01, Volume: 59, Issue:3

    Topics: Appetite; Body Weight; Cachexia; Drug Tolerance; Energy Intake; Humans; Hydrazines; Neoplasms

1987
Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia.
    Cancer, 1967, Volume: 20, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Amines; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Wilms Tumor

1967
[Isoniazid and carcinogenesis].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1969, Oct-26, Volume: 45, Issue:43

    Topics: Adenoma; Adult; Animals; Carbamates; Carcinoma; Child; Clinical Trials as Topic; Female; Humans; Hydrazines; Isoniazid; Lung Neoplasms; Male; Mice; Neoplasms; Neoplasms, Experimental; Pregnancy; Tuberculosis

1969
An industrial view of current practice in predicting drug toxicity.
    British medical bulletin, 1970, Volume: 26, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Cataract; Clinical Trials as Topic; Drug Industry; Fertility; Humans; Hydrazines; Neoplasms; Poisoning; Poliovirus Vaccine, Oral; Thiocarbamates; Toxicology; United States; United States Food and Drug Administration

1970
Combination chemotherapy for 418 cases of advanced cancer.
    Cancer, 1971, Volume: 27, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Synergism; Female; Fluorouracil; History, 16th Century; Humans; Hydrazines; Injections, Intravenous; Laryngeal Neoplasms; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Neoplasms; Prognosis; Time Factors; Tongue Neoplasms; Vinblastine

1971

Other Studies

141 other study(ies) available for hydrazine and Neoplasms

ArticleYear
Mapping vitamin B
    Chemical communications (Cambridge, England), 2021, Oct-19, Volume: 57, Issue:83

    Topics: Cell Line, Tumor; Contrast Media; Humans; Hydrazines; Magnetic Resonance Imaging; Neoplasms; Niacin; Vitamin B 6

2021
A selective Cu
    Scientific reports, 2021, 12-27, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Copper; DNA Cleavage; Drug Discovery; Humans; Hydrazines; Mice; Neoplasms; Phenanthrolines

2021
Cytotoxic benzylidene hydrazides of terephthalic acid and related compounds.
    Die Pharmazie, 2022, 04-10, Volume: 77, Issue:3

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Humans; Hydrazines; Neoplasms; Phthalic Acids

2022
Design, Synthesis and Molecular Docking of Novel Quinazolinone Hydrazide Derivatives as EGFR Inhibitors.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Hydrazines; Molecular Docking Simulation; Molecular Structure; Neoplasms; Protein Kinase Inhibitors; Quinazolinones; Structure-Activity Relationship

2022
Recyclable cell-surface chemical tags for repetitive cancer targeting.
    Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 347

    Topics: Cell Membrane; Click Chemistry; Fluoresceins; Humans; Hydrazines; Ketones; Neoplasms; Polysaccharides; Sugars; Sulfonic Acids

2022
Selinexor synergizes with azacitidine to eliminate myelodysplastic syndrome cells through p53 nuclear accumulation.
    Investigational new drugs, 2022, Volume: 40, Issue:4

    Topics: Azacitidine; Humans; Hydrazines; Myelodysplastic Syndromes; Neoplasms; Triazoles; Tumor Suppressor Protein p53

2022
Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer.
    European journal of medicinal chemistry, 2022, Aug-05, Volume: 238

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydrazines; Mice; Neoplasms

2022
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
    Cancer science, 2022, Volume: 113, Issue:10

    Topics: Animals; Biological Products; Cachexia; Disease Models, Animal; Hydrazines; Mice; Muscle, Skeletal; Muscular Atrophy; Myostatin; Neoplasms; Oligopeptides; Peptides; Receptors, Ghrelin; Transforming Growth Factors

2022
Hydrazides as Potential HDAC Inhibitors: Structure-activity Relationships and Biological Implications.
    Current topics in medicinal chemistry, 2023, Volume: 23, Issue:25

    Topics: Histone Deacetylase Inhibitors; Humans; Hydrazines; Neoplasms; Neurodegenerative Diseases; Structure-Activity Relationship

2023
Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
    ACS applied materials & interfaces, 2023, Aug-09, Volume: 15, Issue:31

    Topics: Cell Line, Tumor; Ferroptosis; Humans; Hydrazines; Indocyanine Green; Infrared Rays; Interferon-gamma; Melanoma; Neoplasms; Programmed Cell Death 1 Receptor; Tumor Microenvironment

2023
Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery.
    Current drug delivery, 2020, Volume: 17, Issue:5

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Hydrazines; Hypoxia; Neoplasms; Prodrugs

2020
A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance.
    PloS one, 2020, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brefeldin A; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; High-Throughput Screening Assays; Humans; Hydrazines; Hydrazones; Neoplasms; Quinolines; Quinuclidines; Sulfonamides; Tyrphostins

2020
Design Strategy for the EPR Tumor-Targeting of 1,2-Bis(sulfonyl)-1-alkylhydrazines.
    Molecules (Basel, Switzerland), 2021, Jan-06, Volume: 26, Issue:2

    Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Hydrazines; Neoplasms; Prodrugs

2021
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies.
    Oncology reports, 2021, Volume: 46, Issue:2

    Topics: Active Transport, Cell Nucleus; Antigens, CD19; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Combined Modality Therapy; Cytoplasm; Exportin 1 Protein; Humans; Hydrazines; Immunotherapy, Adoptive; Karyopherins; Neoplasms; Receptors, Chimeric Antigen; Receptors, Cytoplasmic and Nuclear; STAT3 Transcription Factor; Time Factors; Triazoles

2021
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling.
    Acta biochimica et biophysica Sinica, 2021, Jul-28, Volume: 53, Issue:8

    Topics: A549 Cells; Antineoplastic Agents; Histone Demethylases; Humans; Hydrazines; Janus Kinases; Neoplasm Proteins; Neoplasms; Signal Transduction; STAT3 Transcription Factor; Sulfonamides

2021
Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue: a preliminary study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Volume: 30, Issue:1

    Topics: Counseling; Exercise; Fatigue; Humans; Hydrazines; Longitudinal Studies; Neoplasms; Oligopeptides; Prospective Studies

2022
Bioluminescent Turn-On Probe for Sensing Hypochlorite in Vitro and in Tumors.
    Analytical chemistry, 2017, 06-06, Volume: 89, Issue:11

    Topics: Firefly Luciferin; Hydrazines; Hypochlorous Acid; Limit of Detection; Luminescent Agents; Luminescent Measurements; Molecular Imaging; Neoplasms; Oxidants

2017
Cancer cachexia: Are we ready to take a step forward?
    Cancer, 2018, 02-01, Volume: 124, Issue:3

    Topics: Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Ghrelin; Humans; Hydrazines; Lung Neoplasms; Neoplasms; Oligopeptides

2018
pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
    International journal of biological macromolecules, 2018, Volume: 111

    Topics: Drug Delivery Systems; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrazines; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Silicon Dioxide

2018
Loss of p53 expression in cancer cells alters cell cycle response after inhibition of exportin-1 but does not prevent cell death.
    Cell cycle (Georgetown, Tex.), 2018, Volume: 17, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Lineage; Cell Survival; Exportin 1 Protein; G1 Phase; Humans; Hydrazines; Imidazoles; Karyopherins; Neoplasms; Piperazines; Proto-Oncogene Proteins c-mdm2; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Suppressor Protein p53

2018
N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity.
    Chemistry & biodiversity, 2018, Volume: 15, Issue:10

    Topics: Antineoplastic Agents; Benzoxazines; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Design; Enzyme Activators; Humans; Hydrazines; Neoplasms; Structure-Activity Relationship

2018
Extending Hypochlorite Sensing from Cells to Elesclomol-Treated Tumors in Vivo by Using a Near-Infrared Dual-Phosphorescent Nanoprobe.
    ACS applied materials & interfaces, 2018, Oct-24, Volume: 10, Issue:42

    Topics: Animals; Cell Line, Tumor; Cell Survival; HeLa Cells; Humans; Hydrazines; Hypochlorous Acid; Infrared Rays; Iridium; Luminescence; Mice; Nanoparticles; Neoplasms

2018
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
    Cancer letters, 2019, 07-10, Volume: 454

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; HCT116 Cells; HeLa Cells; Histone Demethylases; Humans; Hydrazines; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Morpholines; Neoplasms; S Phase; Signal Transduction; Sulfones; Thiazoles; TOR Serine-Threonine Kinases; Transcription Factors; Up-Regulation; Xenograft Model Antitumor Assays

2019
Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents.
    Bioorganic chemistry, 2019, Volume: 90

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Drug Design; Drug Screening Assays, Antitumor; Humans; Hydrazines; Molecular Structure; Neoplasms; Pyrimidines; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured

2019
Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Clinical Trials, Phase II as Topic; Computer Simulation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrazines; Male; Middle Aged; Models, Biological; Neoplasms; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia; Treatment Outcome; Young Adult

2013
Influence of phosphate and phosphoesters on the decomposition pathway of 1,2-bis(methylsulfonyl)-1-(2-chloroethyhydrazine (90CE), the active anticancer moiety generated by Laromustine, KS119, and KS119W.
    Chemical research in toxicology, 2014, May-19, Volume: 27, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA; Hydrazines; Intercalating Agents; Mice; Neoplasms; Phosphates; Prodrugs; Sulfonamides

2014
Molecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Annexin A5; Apoptosis; Biotin; Half-Life; HT29 Cells; Humans; Hydrazines; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Confocal; Neoplasms; Phosphatidylserines; Protein Binding; Protein Structure, Tertiary; Radiography; Recombinant Proteins; Streptavidin; Tissue Distribution; Transplantation, Heterologous

2014
Highly cytotoxic DNA-interacting copper(II) coordination compounds.
    Metallomics : integrated biometal science, 2014, Volume: 6, Issue:10

    Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; Cytotoxins; DNA; Humans; Hydrazines; Models, Molecular; Neoplasms

2014
Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
    The Lancet. Oncology, 2015, Volume: 16, Issue:1

    Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anabolic Agents; Analysis of Variance; Appetite Stimulants; Body Composition; Cachexia; Clinical Trials, Phase II as Topic; Female; Humans; Hydrazines; Least-Squares Analysis; Male; Middle Aged; Muscle Strength; Neoplasms; Oligopeptides; Quality of Life; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; United States; Weight Gain; Young Adult

2015
Skeletal muscle anabolism in patients with advanced cancer.
    The Lancet. Oncology, 2015, Volume: 16, Issue:1

    Topics: Anabolic Agents; Appetite Stimulants; Cachexia; Female; Humans; Hydrazines; Male; Neoplasms; Oligopeptides

2015
Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2015, Volume: 45, Issue:8

    Topics: Animals; Antineoplastic Agents; Humans; Hydrazines; Injections, Intravenous; Male; Metalloporphyrins; Models, Animal; Neoplasms; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Sulfonamides; Tissue Distribution

2015
[Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2015, May-01, Volume: 39, Issue:3

    Topics: Aged; Antineoplastic Agents; Benzoates; Female; Humans; Hydrazines; Male; Middle Aged; Neoplasms; Off-Label Use; Pyrazoles; Retrospective Studies; Thrombocytopenia

2015
Hydrazide d-luciferin for in vitro selective detection and intratumoral imaging of Cu(2.).
    Biosensors & bioelectronics, 2016, Sep-15, Volume: 83

    Topics: Animals; Benzothiazoles; Cations, Divalent; Cell Line, Tumor; Copper; Humans; Hydrazines; Luciferases, Firefly; Luminescent Agents; Luminescent Measurements; Mice; Neoplasms; Optical Imaging

2016
Targeting Cancer at the Nuclear Pore.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Volume: 34, Issue:34

    Topics: Animals; Antineoplastic Agents; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Molecular Targeted Therapy; Neoplasms; Nuclear Pore; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Outcome; Triazoles

2016
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; CTLA-4 Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Exportin 1 Protein; Humans; Hydrazines; Immunomodulation; Karyopherins; Melanoma, Experimental; Mice; Neoplasms; Receptors, Cytoplasmic and Nuclear; T-Lymphocytes; Triazoles

2017
Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells.
    Radiation research, 2008, Volume: 170, Issue:5

    Topics: Animals; Antineoplastic Agents; Catalase; Cell Hypoxia; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Glucose; Glucose Oxidase; Humans; Hydrazines; Mice; Neoplasms; Prodrugs; Tumor Cells, Cultured

2008
Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity.
    Cancer biology & therapy, 2009, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Discovery; Female; Flow Cytometry; HT29 Cells; Humans; Hydrazines; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Structure; Neoplasms; Quinoxalines; Xenograft Model Antitumor Assays

2009
Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing.
    BMC cancer, 2010, Apr-17, Volume: 10

    Topics: Animals; Biological Therapy; Biosensing Techniques; Cell Death; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Bacterial; Humans; Hydrazines; Mice; Mice, Inbred BALB C; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Salmonella typhimurium; Time Factors; Tumor Burden

2010
Characterization of short-lived electrophilic metabolites of the anticancer agent laromustine (VNP40101M).
    Chemical research in toxicology, 2011, Apr-18, Volume: 24, Issue:4

    Topics: Acetylcysteine; Antineoplastic Agents; Carbon Isotopes; Chromatography, High Pressure Liquid; Cysteine; Glutathione; Humans; Hydrazines; Magnetic Resonance Spectroscopy; Microsomes, Liver; NADP; Neoplasms; Spectrometry, Mass, Electrospray Ionization; Sulfonamides

2011
99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:10

    Topics: Animals; Biological Transport; Carrier Proteins; Cell Line, Tumor; Drug Stability; Female; Humans; Hydrazines; Luminescent Measurements; Male; Mice; Molecular Imaging; Neoplasms; Niacinamide; Organotechnetium Compounds; Radiochemistry; Spermine; Tomography, Emission-Computed, Single-Photon

2011
Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:12

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Humans; Hydrazines; Models, Molecular; Neoplasms; Pyrazoles; Structure-Activity Relationship

2011
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors.
    International journal of radiation biology, 2012, Volume: 88, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cricetinae; DNA Repair; Humans; Hydrazines; Mammary Neoplasms, Animal; Mice; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Radiation Tolerance; Sulfonamides; Tumor Microenvironment; Xenograft Model Antitumor Assays

2012
Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Dec-06, Volume: 108, Issue:49

    Topics: Amino Acid Sequence; Animals; Annexin A1; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbohydrates; Cell Line, Tumor; Drug Delivery Systems; HCT116 Cells; Humans; Hydrazines; Injections, Intravenous; Irinotecan; Luminescent Measurements; Mice; Mice, Inbred C57BL; Mice, Nude; Molecular Mimicry; Molecular Sequence Data; Neoplasms; Neovascularization, Pathologic; Peptides; Protein Binding; Xenograft Model Antitumor Assays

2011
Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: Acetic Acid; Animals; Antineoplastic Agents; Catalysis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Humans; Hydrazines; Hydrazones; Indoles; Inhibitory Concentration 50; Models, Chemical; Neoplasms; Porifera

2012
The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
    Free radical biology & medicine, 2012, May-15, Volume: 52, Issue:10

    Topics: Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Copper; Humans; Hydrazines; Mitochondria; Neoplasms; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species

2012
NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Shape; Cell Size; DNA Damage; DNA Replication; Drug Screening Assays, Antitumor; Humans; Hydrazines; Inhibitory Concentration 50; Neoplasms; Phosphorylation; Quinoxalines; S Phase Cell Cycle Checkpoints; Tumor Suppressor Protein p53

2012
Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.
    Journal of biomedical optics, 2012, Volume: 17, Issue:10

    Topics: 4-Chloro-7-nitrobenzofurazan; Analysis of Variance; Antineoplastic Agents; Apoptosis; Cell Survival; Choline; Cisplatin; Deoxyglucose; Fluorescent Dyes; HeLa Cells; Humans; Hydrazines; Microscopy, Fluorescence; Molecular Imaging; Neoplasms; Spheroids, Cellular

2012
Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system.
    Nature, 1955, Aug-13, Volume: 176, Issue:4476

    Topics: Azo Compounds; Benzene; Benzene Derivatives; Hydrazines; Neoplasms; Neoplasms, Experimental; Oxidation-Reduction; Oxidoreductases; Xanthine Oxidase; Xanthines

1955
Hydrogen peroxide yields in x-irradiated aqueous solutions; a sensitive method based on hydrazide chemiluminescence.
    Radiation research, 1955, Volume: 3, Issue:4

    Topics: Hydrazines; Hydrogen Peroxide; Luminescence; Neoplasms; X-Rays

1955
Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives.
    Experientia, 1963, Mar-15, Volume: 19

    Topics: Antineoplastic Agents; Cytotoxins; Humans; Hydrazines; Monomethylhydrazine; Neoplasms

1963
The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.
    Experientia, 1963, Mar-15, Volume: 19

    Topics: Antineoplastic Agents; DNA; Hydrazines; Hydrogen Peroxide; Neoplasms

1963
METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HAEMATOSARCOMA AND LEUKAEMIA.
    Lancet (London, England), 1963, Nov-23, Volume: 2, Issue:7317

    Topics: Antineoplastic Agents; Hodgkin Disease; Hydrazines; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma; Vinblastine

1963
[RESULTS OF THE CLINICAL TRIAL OF TREATING CANCER PATIENTS WITH CADMIUM IODIDE AND SEMICARBAZIDE HC1].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Cadmium; Cadmium Compounds; Humans; Hydrazines; Iodides; Neoplasms; Semicarbazides

1963
[RESULTS IN THE TREATMENT OF CANCER PATIENTS WITH SEMICARBAZIDE AND CADMIUM].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Cadmium; Hydrazines; Iodides; Neoplasms; Semicarbazides

1963
[RESULTS OF THE TREATMENT OF PATIENTS WITH NEGLECTED CANCER IN THE LENINGRAD DISTRICT MILITARY HOSPITAL WITH PREPARATIONS PROPOSED BY THE BIOCHEMIST, A. T. KACHUGIN].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Cadmium; Hospitals, Military; Hydrazines; Iodides; Neoplasms; United States

1963
[DATA ON THE RESULTS OF TREATMENT, AT THE UNITED HOSPITAL OF THE MOSCOW DISTRICT OF LENINGRAD, OF CANCER PATIENTS WITH CADMIUM IODIDE AND SEMICARBAZIDE HC1].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Cadmium; Cadmium Compounds; Humans; Hydrazines; Iodides; Moscow; Neoplasms; Semicarbazides

1963
[ON THE USE OF CADMIUM IODIDE AND SEMICARBAZIDE HC1 IN THE TREATMENT OF BLADDER CANCERS].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Cadmium; Cadmium Compounds; Humans; Hydrazines; Iodides; Neoplasms; Semicarbazides; Urinary Bladder Neoplasms

1963
[RESULTS OF THE USE OF SEMICARBAZIDE-CADMIUM THERAPY IN PATIENTS WITH INCURABLE MALIGNANT NEOPLASMS].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Aged; Cadmium; Humans; Hydrazines; Iodides; Neoplasms; Radioisotopes; Semicarbazides

1963
METHYL-HYDRAZINE IN MALIGNANT DISEASE.
    Lancet (London, England), 1963, Dec-14, Volume: 2, Issue:7320

    Topics: Antineoplastic Agents; Humans; Hydrazines; Neoplasms

1963
[STUDIES ON CANCER CHEMOTHERAPY. XIX. SYNTHESIS OF N,N-BIS-(BETA-CHLOROETHYL)-HYDRAZONE DERIVATIVES].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1963, Volume: 10

    Topics: Aldehydes; Androgens; Antineoplastic Agents; Chemistry, Pharmaceutical; Hydrazines; Hydrazones; Methyltestosterone; Neoplasms; Research; Testosterone

1963
[SYNTHESIS OF 2-HALOGENO-4,5-DIALKOXYPHENYLFATTY ACID HYDRAZIDE AND ITS RELATED COMPOUNDS AND THEIR ANTI-CANCER ACTIVITY. (STUDIES ON ANTI-CANCER AGENTS. VII.)].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1963, Volume: 83

    Topics: Antineoplastic Agents; Benzoates; Chemistry, Pharmaceutical; Cinnamates; Hydrazines; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Pharmacy; Phenylacetates; Research

1963
[THE REACTION OF (2-BROMO-4,5-DIMETHOXYPHENYL)-ACETIC ACID HYDRAZIDE WITH VARIOUS CARBONYL COMPOUNDS AND THEIR ANTI-CANCER ACTIVITY. (STUDIES ON ANTI-CANCER AGENTS. VIII.)].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1963, Volume: 83

    Topics: Acetic Acid; Antineoplastic Agents; Chemistry, Pharmaceutical; Hydrazines; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylacetates; Research

1963
[SYNTHESIS OF 2-NITRO-4,5-DIMETHOXYPHENYLFATTY ACID HYDRAZIDE AND ITS RELATED COMPOUNDS AND THEIR ANTI-CANCER ACTIVITY. (STUDIES ON ANTI-CANCER AGENTS. X.)].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1963, Volume: 83

    Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Hydrazines; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Phenylacetates; Research

1963
PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
    Cancer chemotherapy reports, 1963, Volume: 33

    Topics: Antineoplastic Agents; Bone Marrow Diseases; Eosinophilia; Geriatrics; Hemolysis; Hodgkin Disease; Hydrazines; Leukemia; Leukemia, Lymphoid; Lymphocytosis; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Nausea; Neoplasms; Radiography, Thoracic; Toxicology; Vomiting

1963
BICYCLIC IMIDES AND ISOINDOLINES.
    Journal of medicinal chemistry, 1963, Volume: 6

    Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Chemistry, Pharmaceutical; Hydrazines; Imides; Indoles; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180; Tissue Culture Techniques

1963
HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    Journal of medicinal chemistry, 1963, Volume: 6

    Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Hydrazines; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Spectrum Analysis

1963
STUDIES ON METHYLGLYOXAL BIS(GUANYLHYDRAZONE) ANALOGS. I. HOMOLOGS OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE).
    Journal of medicinal chemistry, 1963, Volume: 6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Guanidines; Hydrazines; Leukemia L1210; Leukemia, Experimental; Mitoguazone; Neoplasms; Neoplasms, Experimental; Pharmacology; Pyruvaldehyde; Research; Sarcoma 180

1963
[THE PHARMACOLOGICAL EFFECTS OF THE CYTOSTATIC RO 4-6467 (CLINICAL ASPECTS, HEMATOLOGY AND CYTOLOGY)].
    Archivos del Instituto de Farmacologia Experimental (Medicina), 1964, Volume: 16

    Topics: Antineoplastic Agents; Biomedical Research; Cytostatic Agents; Hematology; Hydrazines; Neoplasms; Pathology; Pharmacology

1964
INDUCTION OF HEPATOMAS IN CBA-CB-SE MICE BY HYDRAZINE SULPHATE AND THE LACK OF EFFECT OF CROTON OIL ON TUMOUR INDUCTION IN BALB-C-CB-SE MICE.
    British journal of cancer, 1964, Volume: 13

    Topics: Animals; Carcinoma, Hepatocellular; Croton Oil; Hydrazines; Isoniazid; Isonicotinic Acids; Liver; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neoplasms; Neoplasms, Experimental; Pathology; Pharmacology; Research; Skin Neoplasms; Sulfates; Toxicology

1964
CURRENT CONCEPTS IN CANCER. 2. HODGKIN'S DISEASE. CHEMOTHERAPY.
    JAMA, 1965, Jan-04, Volume: 191

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydrazines; Lymphatic Metastasis; Neoplasms; Prognosis; Vinblastine

1965
[ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    Revue francaise d'etudes cliniques et biologiques, 1964, Volume: 9

    Topics: Antineoplastic Agents; Hodgkin Disease; Humans; Hydrazines; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Mycosis Fungoides; Neoplasms; Sarcoma

1964
[STUDIES ON THE CYTOSTATIC MECHANISM OF ACTION OF METHYLHYDRAZINE].
    Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1964, Volume: 336

    Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cytostatic Agents; Hydrazines; Methylhydrazines; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research

1964
[THE TREATMENT OF NEOPLASTIC PROCESSES WITH A NEW PRODUCT DERIVED FROM METHYL-HYDRAZINE (RO 4-6467)].
    Revista clinica espanola, 1964, Nov-15, Volume: 95

    Topics: Amino Acids; Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydrazines; Neoplasms; Neoplastic Processes

1964
NATULAN IN MANAGEMENT OF LATE HODGKIN'S DISEASE, OTHER LYMPHORETICULAR NEOPLASMS, AND MALIGNANT MELANOMA.
    British medical journal, 1965, Mar-06, Volume: 1, Issue:5435

    Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Mycosis Fungoides; Neoplasms; Palliative Care; Procarbazine; Toxicology

1965
INTRA-ARTERIAL ADMINISTRATION OF 2-ETHYLHYDRAZIDE OF PODOPHYLLIC ACID (NSC-72274) IN LOCALIZED MALIGNANT DISEASE.
    Cancer chemotherapy reports, 1964, Volume: 43

    Topics: Antineoplastic Agents; Biomedical Research; Drug Therapy; Hydrazines; Injections, Intra-Arterial; Neoplasms; Podophyllotoxin; Podophyllum; Toxicology

1964
[CLINICAL TRIALS OF A METHYLHYDRAZINE DERIVATIVE AND ITS COMBINATION WITH TELECOBALT THERAPY].
    Journal belge de radiologie, 1964, Volume: 47

    Topics: Antineoplastic Agents; Cobalt Isotopes; Drug Therapy; Esophageal Neoplasms; Female; Hodgkin Disease; Humans; Hydrazines; Laryngeal Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methylhydrazines; Neoplasms; Pharyngeal Neoplasms; Radioisotope Teletherapy; Sarcoma; Uterine Cervical Neoplasms

1964
[FIRST EVALUATION OF A METHYLHYDRAZINE IN THE TREATMENT OF MALIGNANT GRANULOMA. PRELIMINARY CLINICAL STUDY].
    Haematologica, 1964, Volume: 49

    Topics: Biomedical Research; Hodgkin Disease; Humans; Hydrazines; Methylhydrazines; Neoplasms

1964
A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.
    Annals of internal medicine, 1965, Volume: 63

    Topics: Alkylating Agents; Antineoplastic Agents; Bone Marrow; Brain; Drug Therapy; Hodgkin Disease; Hydrazines; Leukopenia; Liver; Lung; Methylhydrazines; Neoplasms; Pathology; Pharmacology; Radiography, Thoracic; Thrombocytopenia; Toxicology; Vinblastine

1965
[METHYLHYDRAZINE IN THE TREATMENT OF SOLID TUMORS].
    Pathologie et biologie, 1965, Volume: 13

    Topics: Adolescent; Antineoplastic Agents; Fluorouracil; Geriatrics; Humans; Hydrazines; Methylhydrazines; Neoplasms

1965
[METHYL-BENZYL HYDRAZINE: A NEW CYTOSTATIC. ITS SIDE-EFFECTS IN VITRO AND IN VIVO].
    Zeitschrift fur klinische Medizin, 1965, Apr-29, Volume: 158

    Topics: Antineoplastic Agents; Cytostatic Agents; Hydrazines; In Vitro Techniques; Neoplasms; Pharmacology; Toxicology

1965
TUMOUR CHEMOTHERAPY IN CHILDREN.
    The British journal of clinical practice, 1965, Volume: 19

    Topics: Child; Cyclophosphamide; Dactinomycin; Hodgkin Disease; Humans; Hydrazines; Methotrexate; Neoplasm Metastasis; Neoplasms; Nephrectomy; Neuroblastoma; Nitrogen Mustard Compounds; Orbital Neoplasms; Pelvic Neoplasms; Rhabdomyosarcoma; Vinblastine; Vincristine; Wilms Tumor

1965
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Jun-28, Volume: 102, Issue:26

    Topics: Animals; Antineoplastic Agents; Cell Survival; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Cross-Linking Reagents; Cytochrome-B(5) Reductase; DNA; Dose-Response Relationship, Drug; Edetic Acid; Glutathione; Glutathione Transferase; Hydrazines; Hypoxia; Mice; Mice, Inbred BALB C; Models, Chemical; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Neoplasms; Nitrogen; Oxygen; Sulfhydryl Compounds; Sulfonamides; Time Factors; Treatment Outcome; Xanthine Oxidase; Zinc

2005
Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:11

    Topics: Animals; Antineoplastic Agents; Blotting, Northern; Blotting, Southern; Blotting, Western; Cell Line; Cell Line, Tumor; Disease Progression; DNA Methylation; DNA, Complementary; Dose-Response Relationship, Drug; Gene Silencing; Glycerol; Guanine; Hematopoietic Stem Cells; Hydrazines; Inhibitory Concentration 50; Mice; Models, Chemical; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Prodrugs; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Sulfonamides; Transfection; Tumor Suppressor Protein p53

2005
Estimated effects of hydrazine exposure on cancer incidence and mortality in aerospace workers.
    Epidemiology (Cambridge, Mass.), 2006, Volume: 17, Issue:2

    Topics: Aged; Aviation; Female; Humans; Hydrazines; Incidence; Los Angeles; Male; Middle Aged; Neoplasms; Occupational Diseases; Occupational Exposure; Proportional Hazards Models

2006
Mortality among Rocketdyne workers who tested rocket engines, 1948-1999.
    Journal of occupational and environmental medicine, 2006, Volume: 48, Issue:10

    Topics: Adult; Aviation; California; Cohort Studies; Engineering; Female; Humans; Hydrazines; Industry; Male; Middle Aged; Neoplasms; Occupational Diseases; Occupational Exposure; Retrospective Studies; Solvents; Trichloroethylene

2006
Molecule of the month. Elesclomol and obatoclax mesylate.
    Drug news & perspectives, 2008, Volume: 21, Issue:2

    Topics: Antineoplastic Agents; Controlled Clinical Trials as Topic; Humans; Hydrazines; Indoles; Melanoma; Neoplasm Metastasis; Neoplasms; Pyrroles

2008
The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients.
    British journal of cancer, 1980, Volume: 41, Issue:5

    Topics: Female; Humans; Hydrazines; Male; Neoplasms; Podophyllin; Podophyllotoxin; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms

1980
Percutaneous absorption and chemical carcinogenesis.
    The Journal of dermatology, 1983, Volume: 10, Issue:2

    Topics: Acrylonitrile; Arsenic; Beryllium; Carcinogens; Chloroprene; Chromium; Hair Dyes; Humans; Hydrazines; Neoplasms; Nickel; Nitrosamines; Plastics; Skin Absorption; Styrenes

1983
Occupational exposure to hydrazine and subsequent risk of cancer.
    British journal of industrial medicine, 1984, Volume: 41, Issue:1

    Topics: Chemical Industry; England; Follow-Up Studies; Humans; Hydrazines; Lung Neoplasms; Male; Neoplasms; Occupational Diseases; Risk; Time Factors

1984
Effect of total parenteral nutrition on tumor-host responses in rats.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Animals; Autoradiography; Body Weight; Cachexia; Gluconeogenesis; Hydrazines; Liver Neoplasms, Experimental; Neoplasms; Parenteral Nutrition; Parenteral Nutrition, Total; Rats; Rats, Inbred BUF; Tryptophan

1981
[Application of the microbial mutation test in occupational health and its future problems (author's transl)].
    Sangyo igaku. Japanese journal of industrial health, 1981, Volume: 23, Issue:4

    Topics: Amines; Animals; Carcinogens; Cricetinae; Dogs; Humans; Hydrazines; Mice; Mutagenicity Tests; Mutagens; Neoplasms; Nitro Compounds; Occupational Diseases; Occupational Medicine; Rats

1981
Actual new cancer-causing hydrazines, hydrazides, and hydrazones.
    Journal of cancer research and clinical oncology, 1980, Volume: 97, Issue:2

    Topics: Animals; Cricetinae; Hydrazines; Hydrazones; Mice; Neoplasms; Rats

1980
Occupational exposure to hydrazine and subsequent risk of cancer.
    Occupational and environmental medicine, 1995, Volume: 52, Issue:1

    Topics: Cause of Death; Cohort Studies; Humans; Hydrazines; Male; Neoplasms; Occupational Diseases; Risk Factors; Time Factors

1995
Three stakes in hydrazine sulfate's heart, but questionable cancer remedies, like vampires, always rise again.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Ascorbic Acid; Humans; Hydrazines; Male; Neoplasms; Smoking

1994
Hypoxic mammalian cell radiosensitization by nitric oxide.
    Cancer research, 1993, Dec-15, Volume: 53, Issue:24

    Topics: Animals; Cell Hypoxia; Cell Line; Cell Survival; Cricetinae; Cricetulus; Diethylamines; Hydrazines; Molsidomine; Neoplasms; Nitric Oxide; Nitrogen Oxides; Radiation-Sensitizing Agents

1993
[Drug therapy of cancer cachexia].
    Ugeskrift for laeger, 1994, Jan-10, Volume: 156, Issue:2

    Topics: Antineoplastic Agents; Cachexia; Glucocorticoids; Histamine Antagonists; Humans; Hydrazines; Neoplasms; Progestins

1994
Hydrazine sulfate ad is "offensive".
    Journal of the National Cancer Institute, 1993, Apr-07, Volume: 85, Issue:7

    Topics: Advertising; Cachexia; Humans; Hydrazines; National Institutes of Health (U.S.); Neoplasms; United States

1993
Re: Biology of cachexia.
    Journal of the National Cancer Institute, 1998, Apr-15, Volume: 90, Issue:8

    Topics: Antineoplastic Agents; Cachexia; Disease Progression; Humans; Hydrazines; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Failure

1998
Molecular handles open the door to novel biomaterials and cancer therapies.
    Molecular medicine today, 1998, Volume: 4, Issue:5

    Topics: Biocompatible Materials; Cell Membrane; HeLa Cells; Humans; Hydrazines; Jurkat Cells; Ketones; Mannosides; N-Acetylneuraminic Acid; Neoplasms; Oligosaccharides

1998
More about: biology of cachexia.
    Journal of the National Cancer Institute, 1998, Jul-15, Volume: 90, Issue:14

    Topics: Anti-Anxiety Agents; Antineoplastic Agents; Benzodiazepines; Cachexia; Humans; Hydrazines; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic

1998
Unconventional therapies for cancer: a refuge from the rules of evidence?
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1998, Oct-06, Volume: 159, Issue:7

    Topics: Antineoplastic Agents; Antioxidants; Ascorbic Acid; Attitude to Health; Canada; Clinical Trials as Topic; Complementary Therapies; Cooperative Behavior; Government Agencies; Humans; Hydrazines; Neoplasms; Voluntary Health Agencies

1998
Continuing: Biology of cachexia.
    Journal of the National Cancer Institute, 1999, Jun-16, Volume: 91, Issue:12

    Topics: Antineoplastic Agents; Cachexia; Glucose; Humans; Hydrazines; Neoplasms

1999
Continuing: Biology of cachexia.
    Journal of the National Cancer Institute, 1999, Jun-16, Volume: 91, Issue:12

    Topics: Antineoplastic Agents; Cachexia; Drug Interactions; Humans; Hydrazines; Monoamine Oxidase Inhibitors; Neoplasms; Research Design; Retrospective Studies

1999
Unconventional therapies and cancer.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1999, Sep-21, Volume: 161, Issue:6

    Topics: Antineoplastic Agents; Complementary Therapies; Humans; Hydrazines; Neoplasms; Randomized Controlled Trials as Topic; Research Design

1999
Chemical exposures of rocket-engine test-stand personnel and cancer mortality in a cohort of aerospace workers.
    Journal of occupational and environmental medicine, 1999, Volume: 41, Issue:10

    Topics: Carcinogens; Cohort Studies; Humans; Hydrazines; Logistic Models; Lung Neoplasms; Male; Neoplasms; Occupational Diseases; Occupational Exposure; Retrospective Studies; Risk Assessment

1999
Nitrogen intake and tumorigenesis in rats injected with 1,2-dimethylhydrazine.
    The Journal of nutrition, 1976, Volume: 106, Issue:11

    Topics: Adenocarcinoma; Ammonia; Animals; Blood Urea Nitrogen; Caseins; Cecum; Cholesterol; Colon; Colonic Neoplasms; Dietary Proteins; Dimethylhydrazines; Ear Neoplasms; Female; Hydrazines; Hydrogen-Ion Concentration; Intestinal Neoplasms; Intestine, Small; Neoplasms; Nitrogen; Papilloma; Rats; Urea; Urease

1976
Enhancement of human guanylate cyclase activity by chemical carcinogens.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1977, Volume: 155, Issue:3

    Topics: Enzyme Activation; Guanylate Cyclase; Humans; Hydrazines; Methylnitrosourea; Neoplasms; Nitrosourea Compounds; Solubility; Streptozocin

1977
[Carcinogenic properties of hydrazines].
    Orvosi hetilap, 1977, Dec-11, Volume: 118, Issue:50

    Topics: Animals; Carcinogens; Cricetinae; Humans; Hydrazines; Isoniazid; Neoplasms; Rats

1977
[Acute poisoning by Gyromitra esculenta (author's transl)].
    Toxicological European research. Recherche europeenne en toxicologie, 1978, Volume: 1, Issue:6

    Topics: Chemical Phenomena; Chemistry; Female; Humans; Hydrazines; Male; Mushroom Poisoning; Mycotoxins; Neoplasms

1978
Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients.
    Oncology, 1975, Volume: 32, Issue:1

    Topics: Drug Evaluation; Gluconeogenesis; Humans; Hydrazines; Neoplasms; Paresthesia; Remission, Spontaneous

1975
Supportive care drug studies: some promising, some not.
    Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:9

    Topics: Amifostine; Antineoplastic Agents; Cachexia; Clodronic Acid; Fractures, Spontaneous; Humans; Hydrazines; Neoplasms

1992
National Cancer Institute's evaluation of unconventional cancer treatments.
    Journal of the National Cancer Institute, 1992, Nov-18, Volume: 84, Issue:22

    Topics: Clinical Protocols; Humans; Hydrazines; National Institutes of Health (U.S.); Neoplasms; United States

1992
Hydrazine sulfate may promote caloric intake and increase survival.
    Oncology (Williston Park, N.Y.), 1988, Volume: 2, Issue:3

    Topics: Energy Intake; Humans; Hydrazines; Neoplasms; Survival Rate

1988
Use of exposure registration in the prevention of occupational cancer in Finland.
    American journal of industrial medicine, 1988, Volume: 13, Issue:5

    Topics: Carcinogens; Finland; Humans; Hydrazines; Information Systems; Neoplasms; Occupational Diseases; Occupations; Registries

1988
Hydrazine: epidemiological evidence.
    IARC scientific publications, 1985, Issue:65

    Topics: Humans; Hydrazines; Male; Neoplasms; Occupational Diseases; Time Factors

1985
Pyridine nucleotides in cancer.
    Lancet (London, England), 1965, Dec-04, Volume: 2, Issue:7423

    Topics: Antineoplastic Agents; Humans; Hydrazines; Neoplasms; Nucleotides

1965
[Nucleic acid synthesis and cytostatic drug effect in pathological lymph node cells].
    Medizinische Klinik, 1966, Apr-22, Volume: 61, Issue:16

    Topics: Aged; Antineoplastic Agents; Dactinomycin; Depression, Chemical; DNA, Neoplasm; Hodgkin Disease; Humans; Hydrazines; Hyperplasia; Leukemia; Lymph Nodes; Lymphadenitis; Lymphatic Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms; Nitrogen Mustard Compounds; Nucleosides; Prednisolone; RNA, Neoplasm; Thymidine; Tritium; Vinblastine

1966
[Chemotherapy of solid tumors. Epitheliomas and sarcomas of non-hematopoietic organs].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1971, May-08, Volume: 47, Issue:22

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Drug Synergism; Humans; Hydrazines; Neoplasms; Plant Extracts; RNA, Neoplasm; Sarcoma

1971
Morphological and biochemical effects of 1,2-dimethylhydrazine and 1-methylhydrazine in rats and mice.
    British journal of cancer, 1974, Volume: 30, Issue:5

    Topics: Animals; Colonic Neoplasms; Dimethylhydrazines; Endoplasmic Reticulum; Hydrazines; Kidney Neoplasms; Lethal Dose 50; Leucine; Liver; Male; Mice; Mitochondria; Monomethylhydrazine; Neoplasms; Neoplasms, Experimental; Rats; Ribosomes

1974
Cancer cachexia and gluconeogenesis.
    Annals of the New York Academy of Sciences, 1974, Volume: 230

    Topics: Amino Acids; Animals; Body Weight; Cachexia; Energy Metabolism; Gluconeogenesis; Glucose; Glycolysis; Humans; Hydrazines; Kidney Cortex; Lactates; Liver; Neoplasms; Neoplasms, Experimental; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Tryptophan

1974
[Use of cytostatic drugs in therapy and research].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Mar-10, Volume: 93, Issue:7

    Topics: Alkaloids; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; DNA Replication; Drug Resistance; Ethylamines; Hormones; Humans; Hydrazines; Immunosuppression Therapy; Neoplasms; Nitrogen Mustard Compounds; Transplantation Immunology

1973
The administration of maleic hydrazide and its diethanolamine salt to rats.
    Toxicology, 1973, Volume: 1, Issue:4

    Topics: Animals; Ethanolamines; Female; Fibrosarcoma; Hydrazines; Injections, Subcutaneous; Liver Neoplasms; Male; Maleates; Mammary Neoplasms, Experimental; Neoplasms; Pneumonia; Rats; Time Factors

1973
Species dependent toxicity of six substituted hydrazines.
    Research communications in chemical pathology and pharmacology, 1974, Volume: 7, Issue:4

    Topics: Allyl Compounds; Animals; Benzoates; Benzyl Compounds; Cricetinae; Dose-Response Relationship, Drug; Hydralazine; Hydrazines; Mice; Neoplasms; Species Specificity

1974
[Efficacy of autologous preserved marrow on patients undergoing myelodepressive therapeutic treatment].
    Minerva medica, 1970, Sep-26, Volume: 61, Issue:77

    Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Depression, Chemical; Female; Freezing; Hematopoiesis; Humans; Hydrazines; Injections, Intravenous; Male; Methods; Middle Aged; Neoplasms; Tissue Preservation; Transplantation, Autologous

1970
Combination chemotherapy in malignant disease.
    Clinical radiology, 1971, Volume: 22, Issue:4

    Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Injections, Intravenous; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Multiple Myeloma; Neoplasms; Prednisolone; Radiography; Remission, Spontaneous; Sarcoma, Ewing; Vinblastine

1971
Possibilities of hazard from nitrosamines in industry.
    The Annals of occupational hygiene, 1972, Volume: 15, Issue:1

    Topics: Alkylation; Animals; Carcinogens; Environmental Exposure; Esophageal Neoplasms; Female; Humans; Hydrazines; Liver Neoplasms; Neoplasms; Nitrosamines; Occupational Diseases; Occupational Medicine; Pregnancy; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms

1972
An outline of cancer chemotherapy.
    Revue roumaine d'inframicrobiologie, 1971, Volume: 8, Issue:3

    Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Asparaginase; Breast Neoplasms; Cells, Cultured; Colonic Neoplasms; Cricetinae; DNA, Neoplasm; Humans; Hydrazines; Hydroxyurea; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Mitomycins; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Rats; Ribonucleotides; Ribosomes; RNA, Neoplasm; Transplantation, Heterologous

1971
[Studies on the understanding of problems of radiologic cytostatic combination treatment. 6. Further syncytostatic studies with 5-fluorouracil, natulan and proresid].
    Strahlentherapie, 1969, Volume: 138, Issue:2

    Topics: Amides; Animals; Antineoplastic Agents; Cyclophosphamide; Ear, External; Female; Fluorouracil; Granulation Tissue; Hydrazines; Mice; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Radiation Effects; Radiation Injuries, Experimental; Radiotherapy Dosage; Statistics as Topic; Tail; Wound Healing

1969
1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer.
    Cancer chemotherapy reports, 1969, Volume: 53, Issue:5

    Topics: Administration, Oral; Adult; Antineoplastic Agents; Female; Humans; Hydrazines; Injections, Intravenous; Male; Neoplasms; Picolines

1969
Procarbazine hydrochloride in childhood cancer.
    The Journal of pediatrics, 1969, Volume: 75, Issue:5

    Topics: Adolescent; Adult; Antimetabolites; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neoplasms

1969
[Clinical studies of the method of application of antineoplastic agents].
    Gan no rinsho. Japan journal of cancer clinics, 1970, Volume: 16, Issue:9

    Topics: Antineoplastic Agents; Blood Cell Count; Bone Marrow Examination; Cyclophosphamide; Fluorouracil; Humans; Hydrazines; Injections; Mitomycins; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum

1970
[Results of radiologic and cytostatic combination therapy in malignant diseases].
    Wiener medizinische Wochenschrift (1946), 1967, Jun-24, Volume: 117, Issue:25

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Male; Neoplasms

1967
[Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Minerva radiologica, 1967, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Humans; Hydrazines; Neoplasms

1967
Epidermal pyridine nucleotides: effect of cancer chemotherapeutic agents on uan epidermal pyridine nucleotides.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1968, Feb-03, Volume: 42, Issue:5

    Topics: Alkylating Agents; Amides; Antineoplastic Agents; Humans; Hydrazines; Neoplasms; Nucleotides; Pyridines; Skin

1968
[Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Minerva radiologica, 1968, Volume: 13, Issue:9

    Topics: Antineoplastic Agents; Humans; Hydrazines; Neoplasms; Radiation-Sensitizing Agents

1968
Pharmacologic aspects of the chemotherapy of solid tumors.
    Pharmacology for physicians, 1968, Volume: 2, Issue:9

    Topics: Alkylating Agents; Antineoplastic Agents; Dactinomycin; Folic Acid Antagonists; Humans; Hydrazines; Neoplasms; Pyrimidines; Vinblastine; Vincristine

1968
[Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
    Schweizerische medizinische Wochenschrift, 1965, Sep-11, Volume: 95, Issue:37

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Hemodynamics; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Male; Middle Aged; Neoplasms

1965
The chemotherapy of cancer in children.
    Proceedings of the Royal Society of Medicine, 1966, Volume: 59, Issue:3

    Topics: Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Humans; Hydrazines; Mechlorethamine; Methotrexate; Neoplasms; Vinblastine; Vincristine

1966
[Recent acquisitions in cancer chemotherapy].
    La Presse medicale, 1966, Jun-25, Volume: 74, Issue:32

    Topics: Antineoplastic Agents; Humans; Hydrazines; Neoplasms

1966
[The action of Natulan in 94 cases of solid tumors].
    European journal of cancer, 1966, Volume: 2, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Hydrazines; Male; Middle Aged; Neoplasms

1966
[Recent cytostatic therapy in hemoblastosis and malignant tumors].
    Wiener klinische Wochenschrift, 1966, Jul-01, Volume: 78, Issue:26

    Topics: Antineoplastic Agents; Hematologic Diseases; Humans; Hydrazines; Neoplasms

1966